Plastic surgeons performed 37.5 million aesthetic procedures worldwide in 2024, up 42.5% from 2020. The global aesthetic medicine market reached USD 101.76 billion in 2025 by Fortune Business Insights’ count and USD 98.8 billion by Grand View Research’s estimate. This post covers market size, growth forecasts, procedure volumes, regional splits, and consumer behavior across the latest 2024 to 2026 data.
Aesthetic Medicine Market Statistics – TL;DR
- Global revenue reached USD 101.76 billion in 2025 (Fortune Business Insights) and is projected at USD 280.08 billion by 2034 at an 11.91% CAGR.
- 37.5 million procedures were performed in 2024, a 42.5% rise from 2020, based on ISAPS data.
- Botulinum toxin led all non-surgical treatments with 7.8 million procedures in 2024.
- North America held 36% of the market; Asia-Pacific’s facial injectable segment grows at 16% a year through 2030.
- Non-invasive treatments account for roughly 68% of demand across all practitioners.
The aesthetic medicine market statistics point to steady double-digit growth built on repeat, minimally invasive treatments rather than one-off surgery. Injectables carry the market: Botox alone brought AbbVie’s Allergan Aesthetics USD 5.6 billion worldwide in 2023, about 5.5% of the entire market from a single product. Demand is shifting toward faces and toward Asia, the region ISAPS named its “center of growth.”
How Big Is the Aesthetic Medicine Market?
Six research firms size the market differently based on scope. Fortune Business Insights and Grand View Research land closest, at USD 101.76 billion and USD 98.8 billion for 2025, a 2.9% gap. Coherent Market Insights sits highest at USD 222.03 billion because it folds in wellness services and medical spas. The methodology differences here mirror the way research firms size fast-growing software markets, where scope choices swing headline numbers by tens of billions.
| Research Firm / Scope | 2025 Base | Forecast End | CAGR |
|---|---|---|---|
| Coherent Market Insights (broadest) | USD 222.03B | USD 572.86B (2032) | 14.5% |
| Fortune Business Insights | USD 101.76B | USD 280.08B (2034) | 11.91% |
| Grand View Research | USD 98.8B | USD 240.0B (2033) | 11.9% |
| Research and Markets (TBRC) | USD 74.41B | USD 104.62B (2029) | 8.9% |
| MarketsandMarkets (devices only) | USD 19.54B | USD 40.70B (2031) | 13.0% |
| Medical aesthetics devices sub-market | USD 28.49B | USD 89.59B (2034) | 13.75% |
Source: Fortune Business Insights, Grand View Research, Coherent Market Insights, Research and Markets, MarketsandMarkets (2025-2026)
Aesthetic Medicine Market Size Forecast (2026-2034)
The two closest firms agree on the growth rate almost exactly. Fortune Business Insights projects 11.91% and Grand View Research projects 11.9%, a 0.01 percentage point gap that is the tightest in this research series. Fortune Business Insights sees the market moving from USD 113.87 billion in 2026 to USD 280.08 billion by 2034. Grand View Research reaches USD 240.0 billion by 2033.
| Year | Fortune Business Insights | Grand View Research |
|---|---|---|
| 2025 | USD 101.76B | USD 98.8B |
| 2026 | USD 113.87B | USD 109.2B |
| Forecast end | USD 280.08B (2034) | USD 240.0B (2033) |
Source: Fortune Business Insights (June 2026); Grand View Research (2025)
How Many Aesthetic Procedures Are Performed Worldwide?
ISAPS recorded 37.96 million procedures in 2025, split into 17.42 million surgical and 20.54 million non-surgical treatments. Non-surgical work made up 54.1% of the plastic-surgeon total. In 2024, eyelid surgery overtook liposuction as the most common surgical procedure for the first time on record, a shift toward facial work led by demand in Asia.
| Procedure Metric | Figure | Period |
|---|---|---|
| Total global procedures | 37.5M (+42.5% vs 2020) | 2024 |
| Surgical procedures (ISAPS) | 17.42M | 2025 |
| Non-surgical procedures (ISAPS) | 20.54M | 2025 |
| Botulinum toxin treatments | 7.8M (top non-surgical) | 2024 |
| Eyelid surgery | Overtook liposuction, first on record | 2024 |
Source: ISAPS 2024 and 2025 Global Surveys
Botulinum toxin at 7.8 million treatments equals roughly 21% of all non-surgical procedures by ISAPS count, the single most concentrated procedure in the field.
Aesthetic Medicine Market Statistics By Region
North America led with 36% of the market, or USD 36.63 billion, on Fortune Business Insights’ 2025 base. Grand View Research puts North America at 32.4%, a gap traced to different base years and scope. Europe followed at 28% and Asia-Pacific at 27%. That ranking, with North America ahead and Asia-Pacific climbing fastest, tracks the regional split seen across cloud and consumer-tech markets.
| Region | Share (FBS) | Value (2025) |
|---|---|---|
| North America | 36% | USD 36.63B |
| Europe | 28% | USD 28.49B |
| Asia-Pacific | 27% | USD 27.48B |
| Rest of World | 9% | USD 9.16B |
Source: Fortune Business Insights (2025); regional dollar values calculated from FBS shares
Asia-Pacific
China is the largest country market inside Asia-Pacific at about USD 11.27 billion, and the second-largest nationally after the United States. Japan follows at roughly USD 5.22 billion. The region’s facial injectable segment grows at 16% a year through 2030, triple North America’s pace, and India and China together are projected at USD 2.46 billion in 2026.
United States
The US medical aesthetics market ran USD 8.55 billion in 2025 and is projected at USD 17.45 billion by 2031, per MarketsandMarkets. Facial aesthetics held 61% of US revenue. At-home devices are the fastest-growing sub-segment at 21% a year, while surgical procedures post the fastest revenue growth by procedure type at 12.5%, as surgical fees rise faster than injectable pricing.
Source: MarketsandMarkets, US Medical Aesthetics Market (April 2026)
Aesthetic Medicine Consumer Statistics
Patient demand skews non-surgical. More than 64% of aesthetic patients prefer minimally invasive options, and 57% of patients under 40 choose non-invasive facial treatments. Cost remains the main barrier, with about 43% delaying treatment over affordability. Younger buyers researching treatments online echo the broader pull toward consumer purchasing that starts on digital platforms.
| Consumer Metric | Figure |
|---|---|
| Non-invasive demand (all practitioners) | ~68% |
| Patients preferring minimally invasive | >64% |
| Under-40 choosing non-invasive facial | 57% |
| New patients preferring non-surgical | 52% |
| Adults 35+ seeking anti-aging | ~47% |
| Delaying due to affordability | ~43% |
| Concerned about adverse outcomes | ~31% |
Source: Fortune Business Insights reference document (June 2026)
Aesthetic Medicine Market Statistics: End-Use and Investment
Clinics and aesthetic centers handled about 62% of procedures by end-use, with hospitals at 38%. Roughly 46% of invasive procedures still run through hospitals. On the supply side, 58% of premium clinics raised capital spending, and 38% of product development investment went to AI and robotic systems. That AI push parallels the capital shift toward automation across AI adoption in other sectors.
| Metric | Figure |
|---|---|
| Clinics and aesthetic centers (end-use) | ~62% |
| Hospitals (end-use) | ~38% |
| Premium clinics raising capex | 58% |
| R&D into AI / robotic systems | 38% |
| Premium clinics using AI planning | 36% |
| Therapie Clinic market share | 16% |
| Grand Plastic Surgery market share | 13% |
Source: Fortune Business Insights reference document (June 2026)
AbbVie’s Allergan Aesthetics reported USD 5.2 billion in 2023 revenue, and Botox alone cleared USD 5.6 billion worldwide. Injectables draw pharmaceutical investment because they combine repeat visits every three to six months, brand loyalty, and premium pricing, a mix that also shows up in how consumer health and beauty companies build recurring revenue.
FAQs
How big is the aesthetic medicine market in 2025?
The global aesthetic medicine market was worth USD 101.76 billion in 2025 according to Fortune Business Insights, and USD 98.8 billion according to Grand View Research. The two firms sit within 2.9% of each other.
What is the aesthetic medicine market growth rate?
Fortune Business Insights projects an 11.91% CAGR through 2034 and Grand View Research projects 11.9% through 2033. The 0.01 percentage point gap is the tightest cross-firm agreement in this data set.
How many aesthetic procedures are performed each year?
Plastic surgeons performed 37.5 million procedures in 2024, up 42.5% from 2020. ISAPS logged 17.42 million surgical and 20.54 million non-surgical procedures in its 2025 survey.
Which region leads the aesthetic medicine market?
North America leads with 36% of the market, or USD 36.63 billion, on Fortune Business Insights’ 2025 base. Asia-Pacific grows fastest, with its facial injectable segment expanding 16% a year through 2030.
What is the most common aesthetic procedure?
Botulinum toxin is the most common non-surgical procedure, with 7.8 million treatments in 2024. Eyelid surgery became the most common surgical procedure that year, overtaking liposuction for the first time on record.
Sources
https://www.isaps.org/discover/about-isaps/global-statistics/global-survey-2024-full-report-and-press-releases/
https://www.fortunebusinessinsights.com/industry-reports/medical-aesthetics-market-100631
https://www.companieshistory.com/aesthetic-medicine-market-statistics
https://www.researchandmarkets.com/reports/5939158/aesthetic-medicine-market-report
With many years of professional experience within transnational corporations in different industries, Richard Jaimes has had the opportunity to lead people and organizations, investigate future topics, create strategies and innovations, consult senior management and translate insights into business advantages. Richard is also a long time senior consultant with Quantumrun Foresight.
